News

Oculis Holding AG Announces Participation in Investor Events

Oculis Holding AG Announces Participation in Investor Events

Oculis Holding AG Engaging with Investors at Conferences

Based in Switzerland, Oculis Holding AG (Nasdaq: OCS; Iceland: OCS) is a trailblazer in the biopharmaceutical industry, dedicated to pioneering treatments for ophthalmic and neuro-ophthalmic conditions. Today, Oculis is eager to convey its latest advancements at several prestigious upcoming investor conferences, highlighting its commitment to addressing significant unmet medical needs.

Details About the Conferences

Oculis is slated to make an impression at the Goldman Sachs Annual Healthcare Conference, occurring from June 9 to 11. On June 10, Riad Sherif, MD, the Chief Executive Officer, will engage audiences during a fireside chat scheduled between 9:20 AM and 9:55 AM ET. This event promises to shed light on Oculis' innovative approaches and ongoing projects.

Following that, Oculis will participate in the J.P. Morgan European Healthcare Conference on June 12 in London. Here, Dr. Sherif will again represent the company, discussing developments and future directions.

One-on-One Investor Meetings

The company encourages interested investors to seize the opportunity for personalized discussions during these conferences. Interested parties are advised to coordinate with their respective representatives at the sponsoring institutions to arrange one-on-one meetings that can foster a deeper understanding of Oculis and its strategic vision.

Innovative Pipeline of Oculis

Oculis' impressive pipeline includes a host of innovative product candidates that target a range of eye diseases. Among these is OCS-01, a promising topical eye drop for diabetic macular edema (DME). Additionally, Oculis is developing Privosegtor (OCS-05), a neuroprotective candidate aimed at treating acute optic neuritis, which has potential applications in a variety of other neuro-ophthalmic diseases. Another notable candidate is Licaminlimab (OCS-02), a topical biologic anti-TNF? eye drop targeting dry eye disease (DED).

This diverse portfolio underscores Oculis' commitment to leveraging cutting-edge science to meet the urgent needs of patients around the world. The company's leadership team, equipped with an extensive track record of success, guides Oculis amid a supportive network of international healthcare investors.

Commitment to Investor Communication

Oculis is keen to maintain open lines of communication with investors and stakeholders. When webcasts are available during the conferences, links will be made accessible on their official website's Events & Presentation page under the Investors & Media section, ensuring that all interested parties have access to the latest updates.

About Oculis Holding AG

Oculis Holding AG stands at the forefront of biopharmaceutical innovation, focusing on the unmet medical needs in ophthalmic and neuro-ophthalmic disorders. With operational bases not only in Switzerland but also in the U.S. and Iceland, the company is strategically positioned to advance its therapeutic offerings. Their commitment to innovation is not only reflected in their product pipeline but also in their overarching mission to enhance patient outcomes globally.

For further details, visit www.oculis.com.

Frequently Asked Questions

What is Oculis Holding AG known for?

Oculis Holding AG specializes in developing treatments for ophthalmic and neuro-ophthalmic diseases, addressing critical unmet medical needs.

What conferences is Oculis participating in?

Oculis will participate in the Goldman Sachs Annual Healthcare Conference and the J.P. Morgan European Healthcare Conference.

Who is the CEO of Oculis?

Dr. Riad Sherif serves as the Chief Executive Officer of Oculis Holding AG.

What products are in Oculis' pipeline?

The pipeline includes OCS-01 for diabetic macular edema, Privosegtor for acute optic neuritis, and Licaminlimab for dry eye disease.

How can investors learn more about Oculis?

Investors can access updates and presentations via the Oculis website under the Investors & Media section.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

A. O. Smith Reports Q3 2026: A Strategic Shift

Updated Category News Views 22

A. O. Smith Navigates Change in Third Quarter 2026 It's been a gritty third quarter for A. O. Smith, as the company maneuvers through domestic challenges and crafts a strategic future with international tweaks. They've hammered out $941 million in sales but found themselves grappling with net earnings dipping to $126 million, or $0.93 per diluted share, a mere blip from...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
Banco Macro S.A. Plans $160B Share Buyback Initiative

Updated Category News Views 24

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Continue Reading
Abbe Lane's Estate Auction: Glamour Up for Grabs

Updated Category News Views 72

Glamour from the Mid-Century Comes to the Auction Block In a world obsessed with the flavor of the month, a collection that truly turns heads by sailing in on a wave of genuine mid-century splendor isn't something you stumble upon every day. John Moran Auctioneers has the privilege to crack open the vault on the Estate of Abbe Lane, a name that once rolled off tongues...

Continue Reading
Booming Door Market: $105.93B by 2031, Key Insights

Updated Category News Views 16

Introduction to the Future of the Door Industry Here's what gets me grinning—despite the market doomsayers, there's one industry that's swinging open new opportunities every year: doors. Projected to hit a whopping $105.93 billion by 2031, this market isn't just about hinges and handles. It's a sign of booming construction, urban development, and rising consumer...

Continue Reading
Famous Brands Slashes Fees to Boost Franchise Growth

Updated Category News Views 17

Throwing a Sweet Deal for New Franchise Owners Talk about a move that’s got the industry buzzing—Famous Brands International, the folks behind Mrs. Fields and TCBY, just rolled out a tantalizing offer you don’t see every day. They’re slashing franchise fees and royalties by half for new franchisees who jump onboard before the ball drops on 2026. I’ll tell ya,...

Continue Reading
Fourth PAW Patrol Movie Announced by Spin Master

Updated Category News Views 88

Spin Master and Paramount Roll the Dice Again Ah, Spin Master, you sly devils! Just when we thought they'd caught the last of those daring pups, they're back with another PAW Patrol flick. Yep, a fourth movie is revving up its engines, and this one's coming out of the gates in 2029, thanks to the trio of Spin Master Entertainment, Paramount Animation, and Nickelodeon...

Continue Reading
ZYNLONTA's Japanese Push: ADC Therapeutics Gains Traction

Updated Category News Views 33

ADC Therapeutics Eyes Japan with ZYNLONTA Bet These days, everyone seems to have their eyes on the Far East, and ADC Therapeutics is no exception. They're making a strategic leap by letting their budding blockbuster ZYNLONTA make waves in Japan. With the fresh file submitted for approval, it looks like they're hoping to capture market ground that could pay off big time...

Continue Reading
Oxford Bank Reports Strong Q3 Amid Challenges

Updated Category News Views 0

Digging Into Oxford Bank's Q3 Numbers You ever wonder how a smaller banking outfit yet to become a household name manages to punch above its weight? Let's look at Oxford Bank Corporation's (OTCQX: OXBC) third-quarter antics, where dreams of better margins and loan growth dance, even as operational costs spike. Net Income Climbs Despite Rising Costs The headline here is...

Continue Reading
Bandwidth Welcomes Chip Schroeder: Key Board Makeover

Updated Category News Views 14

Turning the Page at Bandwidth Bandwidth Inc. (NASDAQ:BAND) just shook up its executive roster by bringing in a heavy hitter. Chip Schroeder's landing on the board is a bold move from a strategic player in the cloud communications space. This guy's not your average board member; he's a veteran navigator through stormy market waters, and at Bandwidth, it seems he'll be...

Continue Reading

Top 5 Most Recently Viewed Articles

Aura Minerals Implements Voluntary Delisting from Major Exchange

Updated Category News Views 152

Aura Minerals Plans to Voluntarily Delist from TSX Aura Minerals Inc. (Nasdaq: AUGO) (TSX: ORA) (B3: AURA33) recently announced its intention to apply for a voluntary delisting of its common shares from the Toronto Stock Exchange (TSX). This decision comes after the company's successful listing on Nasdaq, marked on July 16, 2025, and represents a strategic move to align...

Continue Reading
Outbrain Secures $637.5 Million in Senior Secured Notes

Updated Category News Views 129

Outbrain Inc. Successfully Closes New Senior Secured Notes Outbrain Inc. (NASDAQ: OB), now operating under the Teads brand, recently announced a significant development in its financial strategy. The company has successfully completed its Rule 144A/Reg S private offering, raising $637.5 million through the issuance of senior secured notes due in 2030. This transaction,...

Continue Reading
Discover Instant Fashion Shopping with FindGPT from Aesthetic

Updated Category News Views 104

Aesthetic Unveils FindGPT: Revolutionizing Fashion Shopping FindGPT by Aesthetic has officially launched on the App Store, transforming how users can shop for fashionable items found online. This innovative app allows users to turn their fashion inspiration into actionable shopping experiences in just a few taps. Transforming Inspiration into Actionable Shopping Imagine...

Continue Reading
Celebrating Academic Excellence: The Dominguez Firm Scholarships

Updated Category News Views 267

Recognizing the 2025 Scholarship Recipients At The Dominguez Firm, we believe in the power of education and the impact it creates within communities. This spring, we’re proud to honor two outstanding recipients of our scholarship program, Jamie Julien and Eric Lau. Their dedication to academic excellence and commitment to serving their communities truly sets them apart....

Continue Reading
Baxter International Investors Urged to Join Class Action Lawsuit

Updated Category News Views 194

Baxter International Investors Encouraged to Act As challenges continue to mount for Baxter International, Inc. (NYSE: BAX), investors are urged to seek legal assistance regarding a potential class action lawsuit aimed at recovering losses. The lawsuit centers around significant allegations of securities fraud that have affected numerous investors over a defined period....

Continue Reading